Income Statement Valerio Therapeutics London S.E.

Stocks

0NWK

FR0010095596

Pharmaceuticals

Market Closed - London S.E. 09:07:56 14/10/2024 pm IST			After hours 11:11:52 pm
0.0860 ^EUR	-.--%		0.7650	+789.53%

17/08	Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase	MT
16/07	Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies	MT

922e22.ZVc8FfN107AQpMz3Wp6IUtcGc-5NEsP542f_ESbmcxg.IzN0VqAEkfJJ1aGzacnpFptTRr8iQruVhgGJRkjfIik9BWVhgzrq3mfevw

Published financial data: VALERIO THERAPEUTICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	40.62L	14.43L	18L	17.93L	25.73L
Other Revenues, Total	-	-	-	-	-
Total Revenues	40.62L	14.43L	18L	17.93L	25.73L
Cost of Goods Sold, Total	4L	5L	5L	5L	8L
Gross Profit	36.94L	9L	12.67L	12.8L	17.26L
Selling General & Admin Expenses, Total	81.15L	1.8Cr	1.96Cr	1.39Cr	46.8L
Depreciation & Amortization - (IS)	5L	1T	5L	32.61L	11.83L
Other Operating Expenses	7L	25T	3L	6L	-35.87L
Other Operating Expenses, Total	92.76L	1.8Cr	2.03Cr	1.78Cr	22.76L
Operating Income	-55.82L	-1.71Cr	-1.91Cr	-1.65Cr	-6L
Interest Expense, Total	-8L	-21.89L	-1L	-	-3L
Interest And Investment Income	8T	16T	2L	5L	86T
Net Interest Expenses	-8L	-21.73L	34T	5L	-2L
Income (Loss) On Equity Invest.	-	-	-	-80.23L	-37.95L
Currency Exchange Gains (Loss)	-	-3L	-	-	-
Other Non Operating Income (Expenses)	1L	-1L	-74T	-3L	-97T
EBT, Excl. Unusual Items	-62.76L	-1.97Cr	-1.91Cr	-2.43Cr	-46.37L
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	4L	4L	-12.34L	8L	-
EBT, Incl. Unusual Items	-58.37L	-1.93Cr	-2.03Cr	-2.36Cr	-46.37L
Income Tax Expense	1L	3L	17T	4L	3L
Earnings From Continuing Operations	-59.37L	-1.96Cr	-2.03Cr	-2.39Cr	-48.98L
Net Income to Company	-59.37L	-1.96Cr	-2.03Cr	-2.39Cr	-48.98L
Net Income - (IS)	-59.37L	-1.96Cr	-2.03Cr	-2.39Cr	-48.98L
Net Income to Common Incl Extra Items	-59.37L	-1.96Cr	-2.03Cr	-2.39Cr	-48.98L
Net Income to Common Excl. Extra Items	-59.37L	-1.96Cr	-2.03Cr	-2.39Cr	-48.98L
Per Share Items
Net EPS - Basic	-0.07	-0.18	-0.15	-0.16	-0.02
Basic EPS - Continuing Operations	-0.07	-0.18	-0.15	-0.16	-0.02
Basic Weighted Average Shares Outstanding	8.82Cr	11Cr	14Cr	15Cr	27Cr
Net EPS - Diluted	-0.07	-0.18	-0.15	-0.16	-0.02
Diluted EPS - Continuing Operations	-0.07	-0.18	-0.15	-0.16	-0.02
Diluted Weighted Average Shares Outstanding	8.82Cr	11Cr	14Cr	15Cr	27Cr
Normalized Basic EPS	-0.04	-0.12	-0.09	-0.1	-0.01
Normalized Diluted EPS	-0.04	-0.12	-0.09	-0.1	-0.01
Supplemental Items
EBITDA	-55.35L	-1.7Cr	-1.89Cr	-38.96L	34.5L
EBITA	-55.75L	-1.71Cr	-1.91Cr	-42.04L	32.47L
EBIT	-55.82L	-1.71Cr	-1.91Cr	-1.65Cr	-6L
Total Revenues (As Reported)	40.62L	-	-	-	-
Effective Tax Rate - (Ratio)	-1.71	-1.48	-0.08	-1.6	-5.63
Current Foreign Taxes	-1L	5L	2L	4L	-
Total Current Taxes	-1L	5L	2L	4L	3L
Deferred Foreign Taxes	2L	-2L	-2L	-	-
Total Deferred Taxes	2L	-2L	-2L	-	-
Normalized Net Income	-39.22L	-1.23Cr	-1.19Cr	-1.52Cr	-28.98L
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	43T	4L	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	49.04L	1.11Cr	-	51.44L	6L
Stock-Based Comp., SG&A Exp. (Total)	2L	7L	5L	4L	72T
Stock-Based Comp., Other (Total)	-	-	4T	-	-
Total Stock-Based Compensation	2L	7L	5L	4L	72T

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.79Cr	1.46Cr	68.18L	11.78L	10.53L
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	1.79Cr	1.46Cr	68.18L	11.78L	10.53L
Accounts Receivable, Total	85.26L	14.73L	18.89L	17.24L	19.35L
Other Receivables	22.71L	37.77L	29.93L	16.67L	16.37L
Total Receivables	1.08Cr	52.5L	48.82L	33.91L	35.72L
Inventory	-	-	-	-	-
Prepaid Expenses	14.5L	3L	11.67L	-	2L
Other Current Assets, Total	-1T	5L	1L	-	-
Total Current Assets	3.01Cr	2.06Cr	1.3Cr	45.69L	47.79L
Gross Property Plant And Equipment	69.61L	58.22L	59.42L	61.73L	59.44L
Accumulated Depreciation	-47.24L	-39.35L	-44.13L	-50.01L	-46.79L
Net Property Plant And Equipment	22.37L	18.87L	15.29L	11.72L	12.65L
Long-term Investments	-	-	-	-	-
Goodwill	1.81Cr	1.81Cr	1.81Cr	1.2Cr	81.73L
Other Intangibles, Total	0	0	0	-32.59L	-32.6L
Deferred Charges Long-Term	24.72L	24.72L	24.72L	32.59L	32.59L
Other Long-Term Assets, Total	2L	89T	2L	2L	10.18L
Total Assets	5.31Cr	4.31Cr	3.53Cr	1.79Cr	1.52Cr
Liabilities
Accounts Payable, Total	28.32L	34.49L	24.58L	52.47L	22.83L
Accrued Expenses, Total	6L	18.12L	26.2L	17.13L	8L
Short-term Borrowings	-	46T	20.04L	31.27L	7L
Current Portion of Long-Term Debt	29.53L	10.03L	14.47L	72.98L	9L
Current Portion of Leases	5L	3L	3L	3L	2L
Current Income Taxes Payable	2L	5L	6L	6L	9L
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	-	20T	16.9L	-	4L
Total Current Liabilities	70.63L	71.49L	1.11Cr	1.83Cr	63.03L
Long-Term Debt	50.82L	81.04L	69.06L	56.3L	62.32L
Long-Term Leases	14.28L	6L	3L	2L	3L
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	6L	2L	1L	34T	43T
Deferred Tax Liability Non Current	2L	-	-	-	-
Other Non Current Liabilities	57.37L	47.49L	20.12L	20.11L	3L
Total Liabilities	2.01Cr	2.08Cr	2.05Cr	2.62Cr	1.32Cr
Common Stock, Total	2.3Cr	2.79Cr	3.86Cr	2.16Cr	49.94L
Additional Paid In Capital	2.46Cr	2.77Cr	2.9Cr	1.57Cr	2.91Cr
Retained Earnings	-59.37L	-1.96Cr	-5.31Cr	-4.65Cr	-3.19Cr
Treasury Stock	-2L	-81T	-61T	-36T	-
Comprehensive Income and Other	-85.22L	-1.37Cr	4L	3L	-1L
Total Common Equity	3.29Cr	2.23Cr	1.48Cr	-89.3L	20.76L
Minority Interest	-	-	-	7L	-
Total Equity	3.29Cr	2.23Cr	1.48Cr	-82.65L	20.76L
Total Liabilities And Equity	5.31Cr	4.31Cr	3.53Cr	1.79Cr	1.52Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	11Cr	11Cr	15Cr	15Cr	50Cr
ECS Total Common Shares Outstanding	9.16Cr	11Cr	15Cr	15Cr	50Cr
Book Value / Share	0.36	0.2	0.1	-0.06	0
Tangible Book Value	1.49Cr	42.11L	-32.54L	-1.76Cr	-28.37L
Tangible Book Value Per Share	0.16	0.04	-0.02	-0.11	-0.01
Total Debt	99.34L	1.01Cr	1.1Cr	1.66Cr	83.13L
Net Debt	-79.53L	-44.52L	41.84L	1.54Cr	72.6L
Debt Equivalent of Unfunded Proj. Benefit Obligation	6L	2L	1L	34T	43T
Minority Interest, Total (Incl. Fin. Div)	-	-	-	7L	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	-	-	-	-
Machinery, Total	13.45L	-	-	-	-
Full Time Employees	25	25	19	38	25

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-59.37L	-1.96Cr	-2.03Cr	-2.39Cr	-48.98L
Depreciation & Amortization - CF	6L	5L	5L	7L	6L
Amortization of Goodwill and Intangible Assets - (CF)	7T	4T	-	1.23Cr	37.97L
Depreciation & Amortization, Total	6L	5L	5L	1.3Cr	44.29L
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-8L	-
Asset Writedown & Restructuring Costs	-2L	2L	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	2L	7L	5L	4L	72T
Other Operating Activities, Total	9L	17.77L	14.21L	29.84L	10.42L
Change in Other Net Operating Assets	-41.36L	68.75L	-7L	-40.91L	11.94L
Cash from Operations	-85.72L	-94.43L	-1.86Cr	-1.25Cr	18.39L
Capital Expenditure	-1L	-5L	-2L	-3L	-13.18L
Sale of Property, Plant, and Equipment	-	-	-	-	-
Divestitures	-	-	-	-10.8L	-
Investment in Marketable and Equity Securities, Total	73T	80T	7T	9T	2L
Other Investing Activities, Total	-	-1T	-1T	1T	-
Cash from Investing	-66T	-4L	-2L	-13.89L	-11.64L
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	31.07L	-	-	-	-
Total Debt Issued	31.07L	-	-	-	-
Long-Term Debt Repaid, Total	-5L	-15.13L	-12.23L	-13.56L	-8L
Total Debt Repaid	-5L	-15.13L	-12.23L	-13.56L	-8L
Issuance of Common Stock	93.52L	79.74L	1.21Cr	24T	36T
Repurchase of Common Stock	-	-	-1L	-	-
Other Financing Activities, Total	4T	2T	-7T	55.42L	3T
Cash from Financing	1.2Cr	64.63L	1.08Cr	42.1L	-8L
Foreign Exchange Rate Adjustments	25T	87T	2L	-1L	-2T
Miscellaneous Cash Flow Adjustments	-	1T	-	40.91L	-
Net Change in Cash	33.63L	-33.01L	-77.71L	-56.63L	-1L
Supplemental Items
Levered Free Cash Flow	-73.57L	-29.19L	-97.88L	57.66L	-7L
Unlevered Free Cash Flow	-68.27L	-15.51L	-97.02L	57.66L	-6L
Change In Net Working Capital	40.21L	-83.79L	-13.98L	-30.26L	34L
Net Debt Issued / Repaid	26.2L	-15.13L	-12.23L	-13.56L	-8L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-7.01	-22.25	-30.39	-38.74	-2.07
Return on Total Capital	-8.93	-28.42	-40.91	-60.44	-3.68
Return On Equity %	-19.16	-70.86	-109.75	-731.83	158.28
Return on Common Equity	-19.16	-70.86	-109.75	-814.67	142.92
Margin Analysis
Gross Profit Margin %	90.94	64.38	70.39	71.39	67.08
SG&A Margin	199.78	1.25T	1.09T	777.97	181.89
EBITDA Margin %	-136.26	-1.18T	-1.05T	-217.29	134.08
EBITA Margin %	-137.25	-1.19T	-1.06T	-234.47	126.2
EBIT Margin %	-137.42	-1.19T	-1.06T	-919.69	-21.38
Income From Continuing Operations Margin %	-146.16	-1.36T	-1.13T	-1.33T	-190.36
Net Income Margin %	-146.16	-1.36T	-1.13T	-1.33T	-190.36
Net Avail. For Common Margin %	-146.16	-1.36T	-1.13T	-1.33T	-190.36
Normalized Net Income Margin	-96.57	-851.78	-662.95	-848.47	-112.64
Levered Free Cash Flow Margin	-181.11	-202.27	-543.8	321.57	-28.62
Unlevered Free Cash Flow Margin	-168.06	-107.46	-539.01	321.57	-21.79
Asset Turnover
Asset Turnover	0.08	0.03	0.05	0.07	0.16
Fixed Assets Turnover	1.69	0.7	1.05	1.33	2.11
Receivables Turnover (Average Receivables)	0.54	0.29	1.07	0.99	1.41
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	4.27	2.88	1.17	0.25	0.76
Quick Ratio	4.06	2.77	1.05	0.25	0.73
Operating Cash Flow to Current Liabilities	-1.21	-1.32	-1.67	-0.68	0.29
Days Sales Outstanding (Average Receivables)	682.02	1.26T	340.87	368.76	259.53
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	2.77T	2.23T	2.02T	2.75T	1.62T
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	30.16	45.51	74.31	-200.39	400.43
Total Debt / Total Capital	23.17	31.27	42.63	199.61	80.02
LT Debt/Equity	19.76	39.29	48.76	-70.32	314.64
Long-Term Debt / Total Capital	15.18	27	27.97	70.05	62.87
Total Liabilities / Total Assets	37.92	48.31	58.03	146.1	86.37
EBIT / Interest Expense	-6.58	-7.82	-138.07	-	-1.96
EBITDA / Interest Expense	-5.88	-7.58	-134.61	-	13.8
(EBITDA - Capex) / Interest Expense	-6.04	-7.8	-135.93	-	9.11
Total Debt / EBITDA	-1.99	-0.61	-0.59	-4.71	2.14
Net Debt / EBITDA	1.6	0.27	-0.23	-4.38	1.87
Total Debt / (EBITDA - Capex)	-1.94	-0.59	-0.59	-4.32	3.25
Net Debt / (EBITDA - Capex)	1.55	0.26	-0.22	-4.01	2.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	128.72	-64.48	24.74	-0.39	43.5
Gross Profit, 1 Yr. Growth %	158.5	-74.85	36.38	1.03	34.84
EBITDA, 1 Yr. Growth %	-28.02	207.8	11.03	-79.4	-188.55
EBITA, 1 Yr. Growth %	-27.91	206.89	11.36	-77.94	-177.24
EBIT, 1 Yr. Growth %	-28.56	206.57	11.34	-13.45	-96.66
Earnings From Cont. Operations, 1 Yr. Growth %	-645.18	229.49	4	17.63	-79.53
Net Income, 1 Yr. Growth %	-645.18	229.49	4	17.63	-79.53
Normalized Net Income, 1 Yr. Growth %	-23.11	213.35	-2.91	27.49	-80.95
Diluted EPS Before Extra, 1 Yr. Growth %	-799.99	164.28	-18.66	6.34	-87.5
Accounts Receivable, 1 Yr. Growth %	28.13	-82.72	28.24	-8.73	12.24
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-12.69	-15.65	-18.97	-23.35	7.94
Total Assets, 1 Yr. Growth %	14.1	-18.8	-18.13	-49.17	-15.03
Tangible Book Value, 1 Yr. Growth %	35.62	-71.71	-177.27	442.04	-83.92
Common Equity, 1 Yr. Growth %	13.45	-32.4	-33.52	-160.32	-123.25
Cash From Operations, 1 Yr. Growth %	83.24	10.16	96.94	-28.36	-114.76
Capital Expenditures, 1 Yr. Growth %	16.81	251.08	-62.5	75.27	313.17
Levered Free Cash Flow, 1 Yr. Growth %	-18.02	-60.33	235.36	-158.91	-112.77
Unlevered Free Cash Flow, 1 Yr. Growth %	-18.48	-77.29	525.69	-159.43	-109.73
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.68	-9.86	-33.43	11.47	19.56
Gross Profit, 2 Yr. CAGR %	-3.16	-19.37	-41.43	17.38	16.72
EBITDA, 2 Yr. CAGR %	-23.92	48.84	84.87	-52.18	-57.29
EBITA, 2 Yr. CAGR %	-24.55	48.74	84.87	-50.43	-58.72
EBIT, 2 Yr. CAGR %	-24.51	47.99	84.75	-1.84	-83.01
Earnings From Cont. Operations, 2 Yr. CAGR %	-58.04	323.83	85.11	10.6	-50.93
Net Income, 2 Yr. CAGR %	-58.04	323.83	85.11	10.6	-50.93
Normalized Net Income, 2 Yr. CAGR %	-26.15	55.22	74.42	11.25	-50.72
Diluted EPS Before Extra, 2 Yr. CAGR %	-64.43	330.1	46.61	-7	-63.54
Accounts Receivable, 2 Yr. CAGR %	59.46	-52.95	-52.93	8.18	1.21
Inventory, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-11.05	-14.18	-17.33	-21.19	-9.04
Total Assets, 2 Yr. CAGR %	18.75	-3.75	-18.47	-35.49	-34.28
Tangible Book Value, 2 Yr. CAGR %	315.28	-38.05	-53.24	104.66	-6.63
Common Equity, 2 Yr. CAGR %	38.4	-12.42	-32.96	-36.68	-62.55
Cash From Operations, 2 Yr. CAGR %	5.52	42.08	47.29	14.87	-67.48
Capital Expenditures, 2 Yr. CAGR %	131.22	102.51	14.74	-19.15	169.11
Levered Free Cash Flow, 2 Yr. CAGR %	24.63	-42.97	15.35	40.55	-72.57
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.22	-56.97	19.21	92.83	-75.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-12.8	-30.45	0.45	-23.86	21.26
Gross Profit, 3 Yr. CAGR %	-14.51	-38.22	-3.93	-29.76	22.93
EBITDA, 3 Yr. CAGR %	-29.13	21.23	34.99	-11.05	-41.28
EBITA, 3 Yr. CAGR %	-29.1	20.44	35.06	-8.98	-42.53
EBIT, 3 Yr. CAGR %	-29.07	20.44	34.6	43.49	-68.21
Earnings From Cont. Operations, 3 Yr. CAGR %	-14.2	-16.6	165.34	59.15	-36.97
Net Income, 3 Yr. CAGR %	-14.2	-16.6	165.34	59.15	-36.97
Normalized Net Income, 3 Yr. CAGR %	-17.46	19.55	32.75	57.12	-38.22
Diluted EPS Before Extra, 3 Yr. CAGR %	-27.01	-30.59	146.87	31.73	-52.36
Accounts Receivable, 3 Yr. CAGR %	79.3	-23.98	-34.28	-41.31	9.52
Inventory, 3 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	96.24	-12.61	-15.81	-19.38	-12.48
Total Assets, 3 Yr. CAGR %	-5.69	4.62	-8.8	-30.35	-29.29
Tangible Book Value, 3 Yr. CAGR %	-16.26	69.61	-33.32	5.82	-12.34
Common Equity, 3 Yr. CAGR %	-10.14	9	-20.11	-35.28	-54.66
Cash From Operations, 3 Yr. CAGR %	-8.7	7.04	58.41	13.28	-42.04
Capital Expenditures, 3 Yr. CAGR %	45.64	165.76	15.43	31.9	39.26
Levered Free Cash Flow, 3 Yr. CAGR %	-18.09	-14.9	2.94	-7.8	-36.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	-19.34	-27.61	5.03	-5.47	-28.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.69	-31.41	-21.73	-16.01	7.7
Gross Profit, 5 Yr. CAGR %	-0.4	-36.32	-26.51	-20.13	3.85
EBITDA, 5 Yr. CAGR %	-23.63	-0.41	3.99	-16.44	-14.81
EBITA, 5 Yr. CAGR %	-24.79	-2.27	4.02	-15.56	-15.93
EBIT, 5 Yr. CAGR %	-24.77	-2.26	4.02	10.98	-41.18
Earnings From Cont. Operations, 5 Yr. CAGR %	-23.51	-19.83	16.7	-6.63	35.08
Net Income, 5 Yr. CAGR %	-23.51	-19.83	16.7	-6.63	35.08
Normalized Net Income, 5 Yr. CAGR %	-22.26	-0.01	11.34	16.16	-10.69
Diluted EPS Before Extra, 5 Yr. CAGR %	-32.02	-30.85	-3.52	-21.97	14.87
Accounts Receivable, 5 Yr. CAGR %	40.67	21.69	5.02	-12.46	-21.89
Inventory, 5 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	25.69	40.55	38.87	-16.15	-13.16
Total Assets, 5 Yr. CAGR %	-15.76	-11.21	-11.02	-13.78	-20.01
Tangible Book Value, 5 Yr. CAGR %	16.7	-32.39	-33.67	82.85	-23.7
Common Equity, 5 Yr. CAGR %	-18.93	-14.89	-20.08	-12.28	-41
Cash From Operations, 5 Yr. CAGR %	-13.41	-19.7	10.55	10.11	-17.03
Capital Expenditures, 5 Yr. CAGR %	-23.91	49.66	32.39	65.11	61.76
Levered Free Cash Flow, 5 Yr. CAGR %	-7.56	-24.17	-6.07	4.01	-39.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.47	-32.35	-5.7	7.12	-41.77